Opendata, web and dolomites

iMOTED SIGNED

iMOTED Platform Built to improve Clinical Trial outcomes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iMOTED project word cloud

Explore the words cloud of the iMOTED project. It provides you a very rough idea of what is the project "iMOTED" about.

forecasted    individuals    bn    data    quality    beginning    amount    12    sponsors    2022    pharma    collected    predictions       2017    simulations    selling    complexity    software    platform    cumulative    stage    huge    marketed    marketing    market    period    hence    time    exceed    believe    device    registered    breakeven    reduce    ct    day    therapy    initially    business    companies    560    belongs    delayed    multiple    considering    turnover    whom    120    trial    alarms    31    inefficient    industry    designed    upwards    drug    sources    interface    2024    delay    carg    safe    costing    near    clinical    launching    roi    trials    customizable    140    start    point    return    losses    asking    human    prove    estimations    ec    13    licenses    feasibility    investigators    give    perform    employing    generation    usually    clinic    simplify    body    spend    rate    tested    revenues    80    launch    countries    imoted    economic    drugs    intuitive    domestic    opportunity   

Project "iMOTED" data sheet

The following table provides information about the project.

Coordinator
BIODATUP SL 

Organization address
address: PASEO MIKELETEGUI 83
city: SAN SEBASTIAN DONOSTIA
postcode: 20009
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://biodatup.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIODATUP SL ES (SAN SEBASTIAN DONOSTIA) coordinator 50˙000.00

Map

 Project objective

Clinical Trials (CT) are designed to prove if a drug, device or therapy is safe and effective in the human body, so they are already tested in individuals. The CT investigators and sponsors spend great amount of resources on data management and project and data quality control. In 2017 more than 120,000 CT have been registered, of which near 31,000 are carried out in the EU. Usually the average duration of CT from start to marketing is 7.5 years, however, more than 80% of CT are delayed from 1 to 6 month costing to the companies upwards of 30,000 € per day per trial. In most of the cases, this delay is due to inefficient management systems. With CT conducted in over 140 countries, the complexity and rate of change in trials is increasing. Considering this huge business opportunity, we have been working in a customizable software system to manage and simplify CT development. iMOTED platform will ensure high quality data, collected from multiple sources by using real time analysis of data, a simple and intuitive interface, generation of real time alarms employing estimations, predictions & simulations In this way, we expect to reduce the economic losses that pharma industry has when launching a new drug, for whom only 2 out of 10 marketed drugs return revenues that exceed R&D costs. iMOTED belongs to the e-clinic market, which is forecasted to reach €7.6 Bn by 2022 growing at a CARG of 12.4% over the period 2017-2022. We will initially target Europe as our domestic market, to start selling the IMOTED licenses. We expect to have our breakeven point two years after the beginning of the project, a cumulative turnover of €13 M by 2022, that will give us a ROI of 560% in 2024. Hence, at this stage of development we believe that we need to perform a through feasibility study to assess for the challenges and tasks that we still must accomplish to launch iMOTED for what we are asking for EC support.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMOTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMOTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

HAC (2019)

ADVANCED TREATMENT OF CONTAMINATED SOIL

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More